Career summary 

Professor of Health Economics 1/8/16 -

Lead Health Economist for the Norwich Clinical Trials Unit 2013-2018

Reader in Health Economics University of East Anglia 01/08/12 - 31/7/16
 
Deputy Director of the East of England Research Design Service (RDS) (Norfolk and Suffolk region) 01/03/12 - 

Senior Lecturer in Health Economics, University of East Anglia 01/08/09 - 31/07/12

 
Lecturer in Health Economics University of East Anglia 01/08/07 - 31/07/09

ESRC/MRC PhD Studentship University of Nottingham 01/10/04 - 31/7/07

Research Associate MRC Institute of Hearing Research 01/10/01 - 30/9/04

Research Fellow University of York 01/11/98 - 30/9/01

Research Fellow University of Glamorgan 01/10/97 - 30/10/98

Professional Qualifications and professional memberships

Postgraduate Diploma in Higher Education Practice University of East Anglia Pass 2010

PhD. Health Economics University of Nottingham Pass 2007

MSc. Health Economics University of York Pass (with Magellan award) 1998

BA Economics and Sociology University of York 2 (i) 1996

Member of the UK Health Economics Study Group (HESG)

Application and development of the methods of economic evaluation
 

Research design (member of the East of England Research Design Service (RDS) and Norwich Clinical Trials Unit)

Selected research Grants

Selected papers

Peter J. Hutchinson, Hadie Adams, Midhun Mohan, Bhagavatula I. Devi, Christopher Uff, Shumaila Hasan, Harry Mee, Mark H. Wilson, Deepak K. Gupta, Diederik Bulters, Ardalan Zolnourian, Catherine J. McMahon, Matthew G. Stovell, Yahia Z. Al-Tamimi, Manoj K. Tewari, Manjul Tripathi, Simon Thomson, Edoardo Viaroli, Antonio Belli, Andrew T. King, Adel E. Helmy, Ivan S. Timofeev, Sarah Pyne, Dhaval P. Shukla, Dhananjaya I. Bhat, Andrew R. Maas, Franco Servadei, Geoffrey T. Manley, Garry Barton, Carole Turner, David K. Menon, Barbara Gregson, Angelos G. Kolias, for the British Neurosurgical Trainee Research Collaborative, NIHR Global Health Research Group on Acquired Brain and Spine Injury, and RESCUE-ASDH Trial Collaborators. Decompressive Craniectomy vs Craniotomy for Traumatic Acute Subdural Hematoma. New England Journal of Medicine 2023; 338: 2219-2229. DOI: 10.1056/NEJMoa2214172.

Richard Holland, Christine Bond, David Phillip Alldred, Carmel Hughes, Garry Barton, Fiona Poland, Lee Shepstone, Antony Arthur, Linda Birt, Jeanette Blacklock, Annie Blyth, Stamatina Cheilari, Amrit Daffu-O’Reilly, Lindsay Dalgarno, James Desborough, Joanna Ford, Kelly Grant, Bronwen Harry, Helen Hill, Jacqueline Inch, Phyo Kyaw Myint, Nigel Norris, Maureen Spargo, Vivienne Maskrey, David Turner, Laura Watts, Arnold Zermansky, David Wright. The Care Homes Independent Prescribing Pharmacist Study (CHIPPS): A cluster randomised controlled trial to evaluate safety and effectiveness. BMJ 2023, 380, e071883.

Fowler D, Berry C, Hodgekins J, Banerjee R, Barton G, Byrne R, Clarke T, Fraser R., Greenwood K, Notley C, Parker S, Shepstone L, Wilson J, Yung A, French P. PRODIGY: Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness: A definitive randomised controlled trial (RCT) of clinical and cost-effectiveness. Health Technol Assess. 2021: 25: 70. https://doi.org/10.3310/hta25700

Hutchinson PJ, Edlmann E, Bulters D, Zolnourian A, Holton P, Suttner N, Agyemang K, Thomson S, Anderson IA, Al-Tamimi Y, Henderson D, Whitfield P, Gherle M, Brennan PM, Allison A, Thelin EP, Tarantino S, Pantaleo B, Caldwell K, Davis-Wilkie C, Mee H, Warburton EA, Barton G, Chari A, Marcus HJ, King AT, Belli A, Myint PK, Wilkinson I, Santarius T, Turner C, Bond S, Kolias AG, for the British Neurosurgical Trainee Research Collaborative and Dex-CSDH Trial Collaborators. Trial of Dexamethasone for Chronic Subdural Hematoma. New England Journal of Medicine. 2020/12/16

Sampson M, Clark A, Bachmann M, Garner N, Irvine L, Howe A, Greaves C, Auckland S, Smith J, Turner J, Rea D, Rayman G, Dhatariya K, John G, Barton G, Usher R, Ferns C, Pascale M, on behalf of the NDPS group. A lifestyle intervention (with or without lay volunteers) to prevent Type 2 diabetes in people with impaired fasting glucose and/or non-diabetic hyperglycemia: a randomized clinical trial. JAMA Internal Medicine 2021; 181:168-178

Alava MH, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O’Dwyer J, Barton G, Irvine L. An international comparison of EQ-5D-5L and 3L for use in cost effectiveness analysis. Value in Health. 2021: 24: 568-574

Crossman-Barnes CJ, Sach T, Wilson A, Barton G. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics. Quality of Life Research 2020; 29: 619-627

Crossman-Barnes CJ, Sach T, Wilson A, Barton G. Estimating loss in quality of life associated with asthma-related crisis events (ESQUARE): a cohort, observational study. Health and Quality of Life Outcomes 2019; 17:58 https://hqlo.biomedcentral.com/articles/10.1186/s12955-019-1138-5

Quentin Summerfield & Garry Barton. Differential sensitivity of EQ-5D-3L, HUI2, HUI3, and SF-6D to changes in speech reception and annoyance due to tinnitus associated with unilateral cochlear implantation in adults with severe-profound hearing impairment. Quality of Life Research 2019; 28:1145–1154

Twigg MJ, Wright D, Barton G, Kirkdale CL, Thornley T. The Pharmacy Care Plan Service: service evaluation and estimate of cost-effectiveness. Research in Social and Administrative Pharmacy. (2018), https://doi.org/10.1016/j.sapharm.2018.03.062 http://www.rsap.org/article/S1551-7411(17)30838-0/pdf

Hunter SM, Johansen-berg H, Ward N, Kennedy N, Chandler E, Weir CJ, Rothwell J, Wing AM, Grey MJ, Barton G, Leavey NM, Havis C, Lemon R, Burridge J, Dymond A, Pomeroy VM. Functional Strength Training and Movement Performance Therapy for upper limb recovery early post-stroke – efficacy, neural correlates, predictive markers and cost-effectiveness: FAST-INdiCATE trial. Frontiers in Neurology (in press)
http://journal.frontiersin.org/article/10.3389/fneur.2017.00733/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Neurology&id=318923

Crossman-Barnes CJ, Peel A, Fong-Soe-Khioe R, Sach T, Wilson A, Barton G. Economic evidence for non-pharmacological asthma management interventions: A systematic review. Allergy (in press)
http://dx.doi.org/10.1111/all.13337

Alava MH, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O’Dwyer J, Barton G, Irvine L. EQ-5D-5L versus 3L: the impact on cost-effectiveness in the UK. Value in Health. 2018; 21: 49-56.

Fowler D, French P, Banerjee R, Barton G, Berry C, Byrne R, Clarke T, Fraser R, Gee B, Greenwood K, Notley C, Parker S, Shepstone L, Wilson J, Yung AR. Hodgekins J. Prevention and treatment of long term social disability amongst young people with emerging severe mental illness (The PRODIGY Trial): Protocol for a definitive randomised controlled trial of Social Recovery Therapy. Trials. 18, 315.
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-2062-9

Barton GR, Irvine L, Flather M, McCann GP, Curzen N, Gershlick AH, on behalf of the CvLPRIT trial investigators. Economic evaluation of complete revascularisation for patients with multi-vessel disease undergoing primary percutaneous coronary intervention. Value in Health 2017; 20: 745–751
https://www.sciencedirect.com/science/article/pii/S1098301517301134?via%3Dihub

Sackley CM, Walker MF, Burton C, Watkins C, Mant J, Roalfe AK, Wheatley K, Sheehan B, Sharp L, Stant K, Fletcher-Smith J, Steel K, Wilde K, Barton G, Irvine L, Peryer G, on behalf of the OTCH group. An Occupational Therapy intervention for residents with stroke-related disabilities in UK Care Homes (OTCH): cluster randomised controlled trial with economic evaluation. Health Technol Assess 2016;20(15)
http://www.journalslibrary.nihr.ac.uk/hta/volume-20/issue-15

Blyth A, Maskrey V, Notley C, Barton GR, Brown TJ, Aveyard P, Richard Holland, Max O Bachmann,
Stephen Sutton, Jo Leonardi-Bee, Thomas H Brandon, Fujian Song. Effectiveness and economic evaluation of self-help educational materials for the prevention of smoking relapse: randomised controlled trial. Health Technol Assess 2015;19(59). http://www.journalslibrary.nihr.ac.uk/hta/volume-19/issue-59

Twigg M Wright D, Barton G, Thornley T, Kerr C. The four or more medicines (FOMM) support service: results from an evaluation of a new community pharmacy service aimed at over-65s. International Journal of Pharmacy Practice. 2015; 23: 407–414. http://onlinelibrary.wiley.com/doi/10.1111/ijpp.12196/epdf
http://www.communitypharmacyfuture.org.uk/pages/four_or_more_medicines_248974.cfm
Logan PA, Armstrong S, Avery TJ, Barer D, Barton GR, Darby J, et al. Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study). Health Technol Assess 2014;18 (29)
http://www.ncbi.nlm.nih.gov/books/NBK261965/pdf/TOC.pdf

M Goodall,  G Barton, P Bower, P Byrne, JE Cade, S Capewell, C Cleghorn, LA Kennedy, AM Martindale, C Roberts, S Woolf, MB Gabbay. Food for thought: pilot randomised controlled trial of Lay Health Trainers supporting dietary change to reduce cardiovascular disease in deprived communities. Journal of Public Health 2013; 36: 635-643. http://jpubhealth.oxfordjournals.org/content/36/4/635.full.pdf+html      

Barton GR, Fairall L, Bachmann MO, Uebel K, Timmerman V, Lombard C, Zwarenstein M. Cost-effectiveness of nurse-led versus doctor-led antiretroviral treatment in South Africa: Pragmatic cluster randomised trial. Tropical Medicine & International Health 2013; 18: 769-777.
http://onlinelibrary.wiley.com/doi/10.1111/tmi.12093/epdf        

Barton GR, Goodall M, Bower P, Woolf S, Capewell S, Gabbay MB. Increasing heart-health lifestyles in deprived communities: Economic evaluation of lay health trainers. Journal of Evaluation in Clinical Practice 2012; 18: 835-840. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2753.2011.01686.x/epdf

Irvine L, Barton GR, Gasper A, Murray N, Clark A, Scarpello T, Sampson M. Cost effectiveness of a lifestyle intervention in preventing Type 2 diabetes: economic evaluation alongside a clinical trial. International Journal of Technology Assessment in Health Care 2011; 27: 275-282.
http://journals.cambridge.org/download.php?file=%2FTHC%2FTHC27_04%2FS0266462311000365a.pdf&code=bfe4a3e0f452aeb2954f7b01a59f9543            

Barton GR, Sach T, Jenkinson C, Doherty M, Avery A, Muir KR. Lifestyle Interventions for Knee Pain: Cost-effectiveness analysis. British Medical Journal 2009;339:b2273.

Sach T, Barton GR, Jenkinson C, Doherty M, Avery A, Muir KR. Comparing cost-utility estimates: Does the choice of EQ-5D or SF-6D matter? Medical Care 2009; 47: 889-894.

Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Measuring the benefits of treatment for psychosis: The validity and responsiveness of the EQ-5D. British Journal of Psychiatry 2009;195:170-177.

Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis. Schizophrenia Research 2009; 112: 158-163.

Barton GR, Briggs A, Fenwick E. Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value in Health 2008; 11: 886-897.

Barton GR, Sach T, Avery AJ, Jenkinson C, Doherty M, Whynes DK, Muir KR. A comparison of the performance of the EQ-5D and SF-6D for patients aged ≥45 years. Health Economics 2008; 17: 815-832.

Lecturer/Module co-ordinator on the ‘Economic Evaluation’ module of the MSc. in Health Economics, School of Medicine, Health Policy & Practice, University of East Anglia.

Lecturer on the undergraduate MB/BS medical degree  programme, School of Medicine, Health Policy & Practice, University of East Anglia.